PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Directorate of Research, Studies and Documentation, National Public Health Organization, Athens, Greece. Electronic address: maltezou.helena@gmail.com.\', \'Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.\', \'Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.\', \'Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(21)01539-510.1016/j.vaccine.2021.11.066
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34863620
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34863620>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34863620>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all